Our team requires this because prescribing without it is, frankly, reckless
Choose IGF-1 LR3 if: You prefer once-daily dosing for extended research protocols You want sustained, consistent signalling over 20-30 hours Your research spans weeks to months (practical dosing advantage) You want the most widely available option from UK suppliers Choose IGF-1 DES if: You require maximum IGF-1 receptor selectivity without any insulin receptor activity You want the highest possible bioavailability (lowest IGFBP binding) Your research requires more frequent blood sampling or monitoring (shorter half-life allows faster assessment of washout) You prefer more pronounced peaks in signalling for acute study designs Conclusion IGF-1 LR3 and IGF-1 DES are both valuable research tools with distinct advantages
it's associated with a range of adverse health effects that can significantly impact one's quality of life
At Purifi IV Nashville, we empower you to achieve optimal health and well-being with targeted therapies designed to boost your energy, support weight loss, and enhance cellular function
Blood 2008;112, 10051012, doi: Gong, X
doi: 10.1080/0886022x.2018.1489287 106 NolinACMulhernRMPanchenkoMVPisarek-HorowitzAWangZShirihaiOet al